OSTX
OSTX
AMEX · Biotechnology

Os Therapies Inc

$1.36
+0.09 (+7.09%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 10.28M 9.86M 9.80M
Net Income -1,154,434 -865,846 -1,110,362
EPS
Profit Margin -11.2% -8.8% -11.3%
Rev Growth +11.1% +6.2% +2.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 4.74M 4.24M 4.26M
Total Equity 14.89M 15.08M 14.49M
D/E Ratio 0.32 0.28 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,433,621 -1,413,990 -1,277,421
Free Cash Flow -904,387 -870,700 -861,997